WEBINAR VIDEOS
Document ID: PC-SG-101262
Speaker: Prof John Wen-Cheng Chang
6th SSO ASM Lung Track – Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations
Listen to Dr John Wen-Cheng CHANG talk about current and next-generation EGFR-TKIs and their efficacy (ORR, PFS) against uncommon EGFR mutations such as Gly719Xaa, Leu861Gln, and Ser768Ile.
Speaker
John Wen-Cheng Chang, MD
Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan
MORE VIDEOS
30:57
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)
15:12
Efficacy of EGFR-TKIs for Uncommon Mutations Q&A
10:47
